Interleukin-23 drives innate and T cell–mediated intestinal inflammation

Cited by (824)

Items 501–600 of 824

1. Apoptosis and Inflammation: Role of Adipokines in Inflammatory Bowel Disease
   Venkatesh Ponemone, Ali Keshavarzian, Marc I. Brand, Theodore John Saclarides, Herand Abcarian, Robert J. Cabay, Emma Fletcher, Bianca Larsen, Larry Durstine, Giamila Fantuzzi et al. · 2010 · Clinical and Translational Gastroenterology
2. Altered gut microbiome plays an important role in AKI to CKD transition in aged mice
   Myung-Gyu Kim, Won-Yong Cho, Suk Min Chung, Young Eun Choi, Yina Fang, Myeong Soo Park, Sang Jun Park, Yoon Sook Ko, Hee Young Lee, Jihyun Yang et al. · 2023 · Frontiers in Medicine
3. Nutraceuticals in rodent models as potential treatments for human Inflammatory Bowel Disease
   Naga K.R. Ghattamaneni, Sunil K. Panchal, Lindsay Brown · 2018 · Pharmacological Research
4. A Role for Syntaxin 3 in the Secretion of IL-6 from Dendritic Cells Following Activation of Toll-Like Receptors
   Laura E. Collins, Joseph DeCourcey, Keith D. Rochfort, Maja Kristek, Christine E. Loscher · 2015 · Frontiers in Immunology
5. Food-derived bioactives as potential regulators of the IL-12/IL-23 pathway implicated in inflammatory bowel diseases
   Francesca Danesi, Martin Philpott, Claudia Hüebner, Alessandra Bordoni, Lynnette Robyn Ferguson · 2010 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
6. Potential therapeutic utility of mesenchymal stem cells in inflammatory bowel disease in mice
   Ahmed Abdelsalam, Hazem Mahmoud Atta, Tarek M. Salman, Laila Ahmed Rashed, Dina Sabry, Mona F. Schaalan · 2014 · International Immunopharmacology
7. IL-17A Alone Weakly Affects the Transcriptome of Intestinal Epithelial Cells but Strongly Modulates the TNF-α–induced Expression of Inflammatory Mediators and Inflammatory Bowel Disease Susceptibility Genes
   Matthias Friedrich, Julia Diegelmann, Florian Beigel, Stephan Brand · 2014 · Inflammatory Bowel Diseases
8. Experimental Mouse Models of T Cell-Dependent Inflammatory Bowel Disease
   George Xiaoxi Song-Zhao, Kevin Joseph Maloy · 2014 · Methods in molecular biology
9. Immunoproteasome Inhibition Selectively Kills Human CD14+ Monocytes and as a Result Dampens IL-23 Secretion
   Michael Basler, Meike Claus, Moritz Klawitter, Heike Goebel, Marcus Groettrup · 2019 · The Journal of Immunology
10. Distinct inflammatory Th17 subsets emerge in autoimmunity and infection
    Ronald J. Bouch, Jing Zhang, Brandi C. Miller, Caroline J. Robbins, Timothy H. Mosher, Wencheng Li, Sergey A. Krupenko, Ravinder Nagpal, Jun Zhao, Richard S. Bloomfeld et al. · 2023 · The Journal of Experimental Medicine
11. Les lymphocytes TH17 : différenciation, phénotype, fonctions, et implications en pathologie et thérapeutique humaine
    Maxime Samson, Daniela Lakomy, Sylvain Audia, Bernard Bonnotte · 2010 · La Revue de Médecine Interne
12. ICOS promotes IL-17 synthesis in colonic intraepithelial lymphocytes in IL-10−/− mice
    Jeremy S. Schaefer, Dina Montufar‐Solis, Nadarajah Vigneswaran, John R. Klein · 2009 · Journal of Leukocyte Biology
13. Role of regulatory T cells in gastrointestinal inflammatory disease
    Ian Richard van Driel, Desmond K. Y. Ang · 2008 · Journal of Gastroenterology and Hepatology
14. Common pathways in Crohn’s disease and other inflammatory diseases revealed by genomics: Table 1
    Dunecan C. O. Massey, Miles Parkes · 2007 · Gut
15. Investigational drugs in phase I and phase II clinical trials targeting interleukin 23 (IL23) for the treatment of Crohn’s disease
    Christopher Ma, Vipul Jairath, Reena Khanna, Brian G. Feagan · 2018 · Expert Opinion on Investigational Drugs
16. Reducing IRF5 expression attenuates colitis in mice, but impairs the clearance of intestinal pathogens
    Surya Pandey, Jie Yan, Jerrold R. Turner, Clara Abraham · 2019 · Mucosal Immunology
17. The IL-23/IL-17 pathway in human chronic inflammatory diseases – new insight from genetics and targeted therapies
    Elisabetta Bianchi, Lars Rogge · 2019 · Microbes and Infection
18. Association of IL-17, IL-21, and IL-23R Gene Polymorphisms with HBV Infection in Kidney Transplant Patients
    Sara Hejr, Mohammad Hossein Karimi, Ramin Yaghobi, Eskandar Kamali‐Sarvestani, Bita Geramizadeh, Jamshid Roozbeh · 2013 · Viral Immunology
19. The Anaphase-Promoting Complex Protein 5 (AnapC5) Associates with A20 and Inhibits IL-17-Mediated Signal Transduction
    Allen W. Ho, Abhishek V. Garg, Leticia Monin, Michelle R. Simpson-Abelson, Lauren B Kinner, Sarah L. Gaffen · 2013 · PLoS ONE
20. Targeted Therapies in Inflammatory Bowel Disease
    Britta Siegmund · 2009 · Digestive Diseases
21. Genetic Variations of Interleukin-23R (1143A>G) and BPI (A645G), but Not of NOD2, Are Associated with Acute Graft-versus-Host Disease after Allogeneic Transplantation
    Martin Wermke, Stefanie Maiwald, Renate Schmelz, Christian Thiede, Johannes Schetelig, Gerhard Ehninger, Martin Bornhäuser, Ralf Waßmuth · 2010 · Transplantation and Cellular Therapy
22. New and Evolving Immunotherapy in Inflammatory Bowel Disease
    Mohamad A. Raad, Nour Chams, Ala I. Sharara · 2016 · Inflammatory Intestinal Diseases
23. Diagnostic and prognostic value of serum IL-23 in colorectal cancer
    Dina F. El‐Essawi, Manal Mohamed Alkady, I Mohammed Ibrahim · 2019 · Arab Journal of Gastroenterology
24. Microbes, intestinal inflammation and probiotics
    Mohammad Wasim Khan, Amod A Kale, Praveen Bere, Sriharsha Vajjala, Elias G. Gounaris, Krishna Chaitanya Pakanati · 2011 · Expert Review of Gastroenterology & Hepatology
25. Overview of Mouse Models of Inflammatory Bowel Disease and Their Use in Drug Discovery
    Joseph R. Maxwell, Joanne L. Viney · 2009 · Current Protocols in Pharmacology
26. Increased Gastric Cytokine Production After Roux-en-Y Gastric Bypass for Morbid Obesity
    Joel Faintuch · 2007 · Archives of Surgery
27. Host-dependent control of early regulatory and effector T-cell differentiation underlies the genetic susceptibility of RAG2-deficient mouse strains to transfer colitis
    Vassilis Valatas, J He, Aymeric Rivollier, George C. Kolios, K Kitamura, Brian Lee Kelsall · 2012 · Mucosal Immunology
28. Reduced expression of basal and probiotic-inducible G-CSF in intestinal mononuclear cells is associated with inflammatory bowel disease
    Andrew J. Martins, Patrick H D Colquhoun, Gregor Reid, Sung Ouk Kim · 2008 · Inflammatory Bowel Diseases
29. An Emerging Role for SNARE Proteins in Dendritic Cell Function
    Laura E. Collins, Joseph DeCourcey, Mariana Di Luca, Keith D. Rochfort, Christine E. Loscher · 2015 · Frontiers in Immunology
30. IL-17A Induces Hypo-contraction of Intestinal Smooth Muscle via Induction of iNOS in Muscularis Macrophages
    Daisuke Mori, Nobumasa Watanabe, Osamu Kaminuma, Takahisa Murata, Takachika Hiroi, Hiroshi Ozaki, Masatoshi Hori · 2014 · Journal of Pharmacological Sciences
31. Mycobacterium bovis and BCG induce different patterns of cytokine and chemokine production in dendritic cells and differentiation patterns in CD4+ T cells
    Xiansong Zhang, Shuai Li, Yu H. Luo, Yingyu Chen, Cheng Shi, Guangzhi Zhang, Changmin Hu, Huanchun Chen, Aizhen Guo · 2012 · Microbiology
32. Disruption of the Hedgehog signaling pathway in inflammatory bowel disease fosters chronic intestinal inflammation
    Fernanda Buongusto, Cláudio Bernardazzi, Agnes N. Yoshimoto, Hayandra Ferreira Nanini, Raquel Lara Melo Coutinho, Antônio José Carneiro, Morgana Teixeira Lima Castelo-Branco, Heitor Siffert Pereira de Souza · 2016 · Clinical and Experimental Medicine
33. Intestinal Organoids as a Novel Complementary Model to Dissect Inflammatory Bowel Disease
    Lucas-Alexander Schulte, Meike Hohwieler, Madeleine Müller, J Klaus · 2019 · Stem Cells International
34. Act Locally, Act Globally—Microbiota, Barriers, and Cytokines in Atherosclerosis
    Natalia Kurilenko, Aliia R. Fatkhullina, Aleksandra Mazitova, Ekaterina K. Koltsova · 2021 · Cells
35. Helicobacter hepaticus HHGI1 is a pathogenicity island associated with typhlocolitis in B6.129-IL10 mice
    Zhongming Ge, Torsten Sterzenbach, Mark T. Whary, Barry H. Rickman, Arlin B. Rogers, Zeli Shen, Nancy S. Taylor, David B. Schauer, Christine Josenhans, Sebastian Suerbaum et al. · 2008 · Microbes and Infection
36. Anti-IL-23 receptor monoclonal antibody prevents CD4+ T cell-mediated colitis in association with decreased systemic Th1 and Th17 responses
    Emiko Imamura, Katsunari Taguchi, Haruna Sasaki-Iwaoka, Satoshi Kubo, Shigetada Furukawa, Tatsuaki Morokata · 2018 · European Journal of Pharmacology
37. Natural killer cell receptor-expressing innate lymphocytes: more than just NK cells
    Arthur Mortha, Andreas Diefenbach · 2011 · Cellular and Molecular Life Sciences
38. The role of complex interactions between the intestinal flora and host in regulating intestinal homeostasis and inflammatory bowel disease
    Siyu Li, Kan Xu, Yi Cheng, Lu Chen, Ailin Yi, Zhifeng Xiao, Xuefei Zhao, Minjia Chen, Yuting Tian, Meng Wei et al. · 2023 · Frontiers in Microbiology
39. Interleukin-17A and Neutrophils in a Murine Model of Bird-Related Hypersensitivity Pneumonitis
    Masahiro Ishizuka, Yasunari Miyazaki, Masahiro Masuo, Kozo Suhara, Tomoya Tateishi, Makito Yasui, Naohiko Inase · 2015 · PLoS ONE
40. Emerging roles for antigen presentation in establishing host–microbiome symbiosis
    Nicholas J. Bessman, Gregory F. Sonnenberg · 2016 · Immunological Reviews
41. Cytokine related therapies for autoimmune disease
    Terry B. Strom, Maria Koulmanda · 2008 · Current Opinion in Immunology
42. A conserved population of MHC II-restricted, innate-like, commensal-reactive T cells in the gut of humans and mice
    Carl-Philipp Hackstein, Dana Costigan, Linnea Z. Drexhage, Claire F. Pearson, Samuel J. Bullers, Nicholas Edward Ilott, Hossain Delowar Akther, Yisu Gu, Michael E. B. FitzPatrick, Oliver J. Harrison et al. · 2022 · Nature Communications
43. T-bet−/− RAG2−/− ulcerative colitis: The role of T-bet as a peacekeeper of host–commensal relationships
    Wendy S. Garrett, Laurie H. Glimcher · 2009 · Cytokine
44. The Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel Disease
    Hye Won Lee, Sook Hee Chung, Chang Mo Moon, Xiumei Che, Seung Won Kim, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim, Jae Hee Cheon · 2016 · Medicine
45. Innate lymphoid cell-derived cytokines in autoimmune diseases
    Li, Sirui, Yang, Di, Peng, Tingwei, Wu, Yuzhang, Tian, Zhiqiang, Ni, Bing · 2017 · Journal of Autoimmunity
46. Single nucleotide polymorphism rs10889677 in miRNAs Let-7e and Let-7f binding site of IL23R gene is a strong colorectal cancer determinant: Report and meta-analysis
    Meysam Mosallaei, Miganoosh Simonian, Emran Esmaeilzadeh, Hadi Bagheri, Maryam Sadat Miraghajani, Ahmad Reza Salehi, Valiollah Mehrzad, Rasoul Salehi · 2019 · Cancer Genetics
47. A Protective Role for Human IL-10–Expressing CD4+ T Cells in Colitis
    Dilini Ranatunga, Amritha Ramakrishnan, Priyanka Uprety, Fengying Wang, Hao Zhang, Joseph B. Margolick, Cory F. Brayton, Jay H. Bream · 2012 · The Journal of Immunology
48. Raf Signaling but not the ERK Effector SAP-1 Is Required for Regulatory T Cell Development
    Jane E. Willoughby, Patrick S. Costello, Robert H. Nicolas, Nicholas J. Robinson, Gordon Stamp, Fiona M. Powrie, Richard Treisman · 2007 · The Journal of Immunology
49. V617F‐independent upregulation of JAK2 gene expression in patients with inflammatory bowel disease
    Hamid Asadzadeh‐Aghdaei, Kazem Mashayekhi, Khadijeh Koushki, Pedram Azimzadeh, Mohammad Rostami‐Nejad, Davar Amani, Vahid Chaleshi, Saeed Mohammadian Haftcheshmeh, Amirhossein Sahebkar, Mohammad Reza Zali · 2019 · Journal of Cellular Biochemistry
50. Interleukin‐23p19 expression in patients with ulcerative colitis and its relation to disease severity
    Hanan El‐Bassat, Lobna Abo-Ali, Sahar A. El-Yamany, Hanan AlSaeid Alshenawy, Rasha A. Al Din, Amro Ahmed Taha · 2015 · Advances in digestive medicine
51. Implications for a role of interleukin-23 in the pathogenesis of chronic gastritis and of peptic ulcer disease
    Vassilios Koussoulas, Spyridon Vassiliou, Evangelos J. Giamarellos‐Bourboulis, Georgios Tassias, Antigone Kotsaki, Charalampos Barbatzas, Michalis Tzivras · 2008 · Clinical & Experimental Immunology
52. The Current Concept of T H 17 Cells and Their Expanding Role in Systemic Lupus Erythematosus
    Daniel J. Perry, Ammon B. Peck, Wendy C. Carcamo, Laurence M Morel, Cuong Quoc Nguyen · 2011 · Arthritis
53. Interleukin‐23 receptor gene polymorphisms is associated with dilated cardiomyopathy in Chinese Han population
    Y. Chen, Bin Zhou, Y. Peng, Yi Wang, C. Li, Xiang Ding, Xianghua He, J. Xu, L. Huang, Rao Li · 2009 · Tissue Antigens
54. IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy
    Federica Furfaro, Daniela Gilardi, Mariangela Allocca, Clelia Cicerone, Carmen Correale, Gionata Fiorino, Silvio Danese · 2017 · Expert Review of Clinical Immunology
55. Biological Therapy for Inflammatory Bowel Disease
    Raquel Franco Leal, Tristan Torriani · 2019 · IntechOpen eBooks
56. Microbiota and Gut Health: Promising Prospects for Clinical Trials from Bench to Bedside
    Jie Wang, Puxuan Zhang, Shujie Chen, Huimin Duan, Liwei Xie · 2022 · Advanced Gut & Microbiome Research
57. Divergent roles for STAT4 in shaping differentiation of cytotoxic ILC1 and NK cells during gut inflammation
    Gianluca Scarno, Julija Mazej, Mattia Laffranchi, Chiara Di Censo, Irene Mattiola, Arianna Maria Candelotti, Giuseppe Pietropaolo, Helena Stabile, Cinzia Fionda, Giovanna Peruzzi et al. · 2023 · Proceedings of the National Academy of Sciences
58. Genetic Analysis of Ulcerative Colitis in Japanese Individuals Using Population-specific SNP Array
    Daisuke Okamoto, Yosuke Kawai, Yoichi Kakuta, Takeo Naito, Takehiro Torisu, Atsushi Hirano, Junji Umeno, Yuta Fuyuno, Dalin Li, Takeru Nakano et al. · 2020 · Inflammatory Bowel Diseases
59. Recent advances in inflammatory bowel disease therapy
    Agata Binienda, Jakub Fichna, Maciej Sałaga · 2020 · European Journal of Pharmaceutical Sciences
60. Comparison of different sources of mesenchymal stem cells: focus on inflammatory bowel disease
    Lihao Shi, Leilei Chen, Xizhuang Gao, Xufan Sun, Guiyuan Jin, Yonghong Yang, Yiming Shao, Fengqin Zhu, Guangxi Zhou · 2024 · Inflammopharmacology
61. Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitis
    Fumitaka Terabe, Minoru Fujimoto, Satoshi Serada, Shinichiro Shinzaki, Hideki Iijima, Masahiko Tsujii, Norio Hayashi, Shintaro Nomura, Hirohisa Kawahata, Myoung Ho Jang et al. · 2010 · Inflammatory Bowel Diseases
62. Emerging therapies for the treatment of ulcerative colitis
    Nicola Pugliese, Giulia Roda, Laurent Peyrin‐Biroulet, Silvio Danese · 2020 · Expert Opinion on Emerging Drugs
63. Innate lymphoid cells are pivotal actors in allergic, inflammatory and autoimmune diseases
    Golshid Sanati, Zahra Aryan, Mehri Barbadi, Nima Rezaei · 2015 · Expert Review of Clinical Immunology
64. Colonization and effector functions of innate lymphoid cells in mucosal tissues
    Kim, Myunghoo, Kim, Chang H. · 2016 · Microbes and Infection
65. Glucocorticoid-Induced Leucine Zipper as a Druggable Target in Inflammatory Bowel Diseases
    Simona Ronchetti, Marco Gentili, Erika Ricci, Graziella Migliorati, Carlo Riccardi · 2020 · Inflammatory Bowel Diseases
66. Chapter 2 New Insights into the Roles of Dendritic Cells in Intestinal Immunity and Tolerance
    Vuk Cerovic, Victoria McDonald, Mark A. Nassar, Susan M. Paulin, G. Gordon MacPherson, Simon W. F. Milling · 2008 · International review of cytology
67. Association of peroxisome proliferator-activated receptor gamma polymorphisms with inflammatory bowel disease in a Hungarian cohort
    Szilárd Póliska, András Penyige, Peter Laszlo Lakatos, Mária Papp, Károly Palatka, Laszlo Lakatos, Tamás Molnár, László Nagy · 2011 · Inflammatory Bowel Diseases
68. The application and relevance of ex vivo culture systems for assessment of IBD treatment in murine models of colitis
    Maria Fritsch Fredin, Alexander Vidal, Helena Utkovic, Yu-Yuan Chiu Götlind, Roger Wïllén, Liselotte Jansson, Elisabeth Hultgren Hörnquist, Silvia Melgar · 2008 · Pharmacological Research
69. New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?
    Silvio Danese, Emanuele Angelucci · 2009 · Gastroentérologie Clinique et Biologique
70. Massive but selective cytokine dysregulation in the colon of IL-10−/− mice revealed by multiplex analysis
    Dina Montufar‐Solis, Jeremy S. Schaefer, John M. Hicks, John R. Klein · 2007 · International Immunology
71. Evaluation of interleukin 23 (IL-23) as a non-invasive test of disease severity in patients with ulcerative colitis
    Tarek Mohammed Youssef, Shereen Abo Baker Saleh, Angie Rund, Iman Fawzy Montasser, Manal Mohsen, Ola Hazem · 2018 · Arab Journal of Gastroenterology
72. Genetic variants in the IL12B gene are associated with inflammatory bowel diseases in the K orean population
    Chang Mo Moon, Dong‐Jik Shin, Nak‐Hoon Son, Eun‐Soon Shin, Sung Pil Hong, Tae Il Kim, Won Ho Kim, Jae Hee Cheon · 2013 · Journal of Gastroenterology and Hepatology
73. The Straw That Stirs the Drink: Insight into the Pathogenesis of Inflammatory Bowel Disease Revealed Through the Study of Microflora-Induced Inflammation in Genetically Modified Mice
    Bruce Harold Horwitz · 2007 · Inflammatory Bowel Diseases
74. Toll-like receptor 5 deficiency protects from wasting disease in a T cell transfer colitis model in T cell receptor-β-deficient mice
    Gijs Hardenberg, Yu Feng Yao, Ciriaco A. Piccirillo, Megan K. Levings, Theodore S. Steiner · 2011 · Inflammatory Bowel Diseases
75. Review article: the intersection of mucosal pathophysiology in HIV and inflammatory bowel disease, and its implications for therapy
    T. H. Ho, Benjamin L. Cohen, J F Colombel, Saurabh Mehandru · 2014 · Alimentary Pharmacology & Therapeutics
76. Ultra-endurance triathlon performance and markers of whole-body and gut-specific inflammation
    Kyle A. Smith, Jacob N. Kisiolek, Brandon D. Willingham, Margaret C. Morrissey, Samantha M. Leyh, Patrick G. Saracino, Daniel Baur, Marc D. Cook, Michael J. Ormsbee · 2019 · European Journal of Applied Physiology
77. The binding activity of Mel‐18 at the Il17a promoter is regulated by the integrated signals of the TCR and polarizing cytokines
    Reut Hod-Dvorai, Eyal Jacob, Yulia Boyko, Orly Avni · 2011 · European Journal of Immunology
78. Regulation of Protective and Pathogenic Th17 Responses
    Gottfried Alber, Thomas Kamradt · 2007 · Current Immunology Reviews
79. Adaptive immunity in inflammatory bowel disease: state of the art
    Arthur Kaser, Richard S. Blumberg · 2008 · Current Opinion in Gastroenterology
80. Effects of Anti-Cytokine Antibodies on Gut Barrier Function
    Fang Liu, Seul A. Lee, Stephen M. Riordan, Li Zhang, Lixin Zhu · 2019 · Mediators of Inflammation
81. L’IL-23R, un nouveau gène de susceptibilité dans les maladies inflammatoires chroniques intestinales
    Laurent Peyrin‐Biroulet, Erika Parmentier-Decrucq, Julien Branche, Pierre Desreumaux · 2007 · médecine/sciences
82. Common flora and intestine
    Kepeng Wang, Michael Karin · 2013 · Cellular Logistics
83. Genome-wide association scans identify multiple confirmed susceptibility loci for Crohnʼs disease: Lessons for study design
    Mark Tremelling, Miles Parkes · 2007 · Inflammatory Bowel Diseases
84. Exploring Colitis through Dynamic T Cell Adoptive Transfer Models
    Wenjing Yang, Yingzi Cong · 2023 · Inflammatory Bowel Diseases
85. Structure-aware deep model for MHC-II peptide binding affinity prediction
    Yingyan Yu, Lipeng Zu, Jiaye Jiang, Yafang Wu, Yinglin Wang, Midie Xu, Qing Liu · 2024 · BMC Genomics
86. AIEC-dependent pathogenic Th17 cell transdifferentiation in Crohn’s disease is suppressed by rfaP and ybaT deletion
    Gabriella Leccese, Matteo Chiara, Irene Dusetti, Daniele Noviello, Elisabeth Billard, A. Bibi, G. Conte, Clarissa Consolandi, Maurizio Vecchi, MP Conte et al. · 2024 · Gut Microbes
87. Down the line from genome-wide association studies in inflammatory bowel disease: the resulting clinical benefits and the outlook for the future
    Lieke M. Spekhorst, Marijn Caroline Visschedijk, Rinse Karel Weersma, Eleonora Anna Margaretha Festen · 2014 · Expert Review of Clinical Immunology
88. IL-23 Contributes to Campylobacter jejuni-Induced Intestinal Pathology via Promoting IL-17 and IFNγ Responses by Innate Lymphoid Cells
    Xi Jing, Anna A. Korchagina, Sergey A. Shein, Wayne T. Muraoka, Ekaterina P. Koroleva, Alexei V. Tumanov · 2021 · Frontiers in Immunology
89. Gut Commensal-Induced IκBζ Expression in Dendritic Cells Influences the Th17 Response
    Lena Michaelis, Marcel Treß, Hanna-Christine Löw, Johanna Klees, Christian Klameth, Anna Lange, Anne Grießhammer, Andrea Schäfer, Sarah Menz, Alex Steimle et al. · 2021 · Frontiers in Immunology
90. Cytokines in Inflammatory Bowel Disease
    Matthias A. Engel, Markus Friedrich Neurath · 2013 · Springer eBooks
91. Immunologic and genetic links between spondylarthropathies and inflammatory bowel diseases.
    Francesca Faustini, A. Zoli, Gianfranco Ferraccioli · 2009 · PubMed
92. Impact of the IL-17F, IL-23 and IL-23R on susceptibility and phenotype of systemic lupus erythematosus
    Agnieszka Paradowska‐Gorycka, Anna Sowińska, Barbara Stypińska, Malwina Grobelna, Marcela Walczyk, Marzena Olesińska, Piotr Piotrowski, Paweł Piotr Jagodziński · 2016 · Autoimmunity
93. A Role for IL-12 in IBD after All?
    Carrie N. Arnold Greving, Jennifer E. Towne · 2019 · Immunity
94. Inherent low Erk and p38 activity reduce Fas Ligand expression and degranulation in T helper 17 cells leading to activation induced cell death resistance
    Doureradjou Peroumal, Thiruvaimozhi Abimannan, Ravichandra Tagirasa, Jyoti Ranjan Parida, Santosh Kumar Singh, Prasantha Padhan, Satish Devadas · 2016 · Oncotarget
95. New Interleukin-23 Antagonists’ Use in Crohn’s Disease
    Laura Biskup, Jan Semeradt, Jagoda Rogowska, Wiktoria Chort, Łukasz Durko, Ewa Małecka-Wojciesko · 2025 · Pharmaceuticals
96. USP19 Suppresses Th17-Driven Pathogenesis in Autoimmunity
    Jing Zhang, Ronald J. Bouch, Maxim G Blekhman, Zhiheng He · 2021 · The Journal of Immunology
97. Elevated IL-23R Expression and Foxp3+Rorgt+ Cells in Intestinal Mucosa During Acute and Chronic Colitis
    Jiayin Yang, Lili Xu · 2016 · Medical Science Monitor
98. Tildrakizumab for the Treatment Of Psoriasis
    Christine Bangert, Tamara Kopp · 2018 · Immunotherapy
99. Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?
    Marjorie Costa ARGOLLO, Mariangela Allocca, Federica Furfaro, Laurent Peyrin‐Biroulet, Silvio Danese · 2019 · Current Pharmaceutical Design
100. Age and CD161 Expression Contribute to Inter-Individual Variation in Interleukin-23 Response in CD8+ Memory Human T Cells
     Hui Shen, Wei Zhang, Clara Abraham, Judy H. Cho · 2013 · PLoS ONE